nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.161	0.672	CbGbCtD
Glucosamine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0787	0.329	CbGbCtD
Glucosamine—Streptozocin—ABCB1—peripheral nervous system neoplasm	0.00433	1	CrCbGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.00257	0.0034	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00255	0.00338	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—NRAS—peripheral nervous system neoplasm	0.00255	0.00338	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—AKT1—peripheral nervous system neoplasm	0.00253	0.00335	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—MYC—peripheral nervous system neoplasm	0.00252	0.00333	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—ERBB2—peripheral nervous system neoplasm	0.0025	0.00331	CbGpPWpGaD
Glucosamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00248	0.00328	CbGpPWpGaD
Glucosamine—NFKB2—TSLP Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00241	0.00318	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00239	0.00316	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CASP3—peripheral nervous system neoplasm	0.00238	0.00315	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—NRAS—peripheral nervous system neoplasm	0.0023	0.00304	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—PPP3R1—peripheral nervous system neoplasm	0.0023	0.00304	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00229	0.00303	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NF1—peripheral nervous system neoplasm	0.00224	0.00296	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IFNB1—peripheral nervous system neoplasm	0.00223	0.00294	CbGpPWpGaD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—peripheral nervous system neoplasm	0.00222	0.00293	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—PTPN11—peripheral nervous system neoplasm	0.00222	0.00293	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—CDKN2A—peripheral nervous system neoplasm	0.00218	0.00289	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.00218	0.00288	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.00217	0.00287	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—ABCB1—peripheral nervous system neoplasm	0.00217	0.00287	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.00217	0.00286	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—PPP3R1—peripheral nervous system neoplasm	0.00216	0.00285	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IFNB1—peripheral nervous system neoplasm	0.00214	0.00283	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.00214	0.00282	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—CASP3—peripheral nervous system neoplasm	0.00213	0.00282	CbGpPWpGaD
Glucosamine—NFKB2—RANKL/RANK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00212	0.00281	CbGpPWpGaD
Glucosamine—IFNG—IFN-gamma pathway—AKT1—peripheral nervous system neoplasm	0.0021	0.00277	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.00209	0.00277	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.00208	0.00275	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.00206	0.00272	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00205	0.00271	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.00204	0.0027	CbGpPWpGaD
Glucosamine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00201	0.00266	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—CASP3—peripheral nervous system neoplasm	0.00198	0.00262	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—HRAS—peripheral nervous system neoplasm	0.00198	0.00262	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—HRAS—peripheral nervous system neoplasm	0.00198	0.00262	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—NRAS—peripheral nervous system neoplasm	0.00192	0.00253	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—NRAS—peripheral nervous system neoplasm	0.0019	0.00252	CbGpPWpGaD
Glucosamine—NFKB2—Neural Crest Differentiation—MYC—peripheral nervous system neoplasm	0.00188	0.00249	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.00187	0.00247	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—HRAS—peripheral nervous system neoplasm	0.00187	0.00247	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00184	0.00243	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—CASP3—peripheral nervous system neoplasm	0.00183	0.00242	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.00183	0.00242	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BIRC5—peripheral nervous system neoplasm	0.00183	0.00242	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—PTPN11—peripheral nervous system neoplasm	0.0018	0.00239	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—MYC—peripheral nervous system neoplasm	0.00177	0.00234	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.00176	0.00233	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IFNB1—peripheral nervous system neoplasm	0.00174	0.0023	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00173	0.00228	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00172	0.00227	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD55—peripheral nervous system neoplasm	0.00171	0.00226	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.0017	0.00225	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—HRAS—peripheral nervous system neoplasm	0.00168	0.00223	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00168	0.00222	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TNFSF10—peripheral nervous system neoplasm	0.00166	0.0022	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.00165	0.00218	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.00165	0.00218	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00164	0.00218	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.00164	0.00217	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00162	0.00214	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.0016	0.00212	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00159	0.00211	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.00159	0.0021	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PTPN11—peripheral nervous system neoplasm	0.00158	0.00209	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00157	0.00208	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00155	0.00205	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.00149	0.00197	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.00148	0.00196	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.00148	0.00196	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—peripheral nervous system neoplasm	0.00146	0.00192	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.00145	0.00192	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—CASP3—peripheral nervous system neoplasm	0.00143	0.0019	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00143	0.00189	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.00141	0.00186	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00141	0.00186	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	0.0014	0.00185	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.00139	0.00184	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—HRAS—peripheral nervous system neoplasm	0.00139	0.00184	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD55—peripheral nervous system neoplasm	0.00138	0.00183	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.00135	0.00178	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00133	0.00176	CbGpPWpGaD
Glucosamine—MMP9—FGF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00132	0.00175	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NTRK1—peripheral nervous system neoplasm	0.00132	0.00174	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00131	0.00173	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—HRAS—peripheral nervous system neoplasm	0.00131	0.00173	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00131	0.00173	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00131	0.00173	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.0013	0.00171	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD34—peripheral nervous system neoplasm	0.00129	0.00171	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—MYC—peripheral nervous system neoplasm	0.00128	0.0017	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00128	0.0017	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00127	0.00168	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—peripheral nervous system neoplasm	0.00127	0.00168	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.00125	0.00165	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	0.00125	0.00165	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PPP3R1—peripheral nervous system neoplasm	0.00124	0.00165	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—AKT1—peripheral nervous system neoplasm	0.00123	0.00162	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	0.00121	0.00161	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDKN2A—peripheral nervous system neoplasm	0.00121	0.0016	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BDNF—peripheral nervous system neoplasm	0.00121	0.0016	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	0.0012	0.00159	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00119	0.00157	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	0.00116	0.00154	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.00116	0.00153	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	0.00116	0.00153	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—AKT1—peripheral nervous system neoplasm	0.00116	0.00153	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.00113	0.00149	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.00111	0.00146	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.0011	0.00146	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CASP3—peripheral nervous system neoplasm	0.0011	0.00146	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NCAM1—peripheral nervous system neoplasm	0.0011	0.00145	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00109	0.00144	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00107	0.00142	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—peripheral nervous system neoplasm	0.00107	0.00141	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—peripheral nervous system neoplasm	0.00105	0.00139	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD34—peripheral nervous system neoplasm	0.00105	0.00138	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.00104	0.00138	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.00102	0.00135	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.00101	0.00134	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PPP3R1—peripheral nervous system neoplasm	0.00101	0.00133	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000991	0.00131	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000977	0.00129	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000962	0.00127	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	0.000951	0.00126	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.000929	0.00123	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—peripheral nervous system neoplasm	0.000918	0.00121	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000894	0.00118	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NCAM1—peripheral nervous system neoplasm	0.00089	0.00118	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—AKT1—peripheral nervous system neoplasm	0.00089	0.00118	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MET—peripheral nervous system neoplasm	0.000879	0.00116	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNB1—peripheral nervous system neoplasm	0.000862	0.00114	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000862	0.00114	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000839	0.00111	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000834	0.0011	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—peripheral nervous system neoplasm	0.000822	0.00109	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MYC—peripheral nervous system neoplasm	0.00082	0.00109	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000819	0.00108	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000817	0.00108	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000813	0.00107	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000803	0.00106	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000801	0.00106	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—AKT1—peripheral nervous system neoplasm	0.000798	0.00106	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—peripheral nervous system neoplasm	0.000782	0.00103	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—AKT1—peripheral nervous system neoplasm	0.000776	0.00103	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	0.000725	0.000958	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000721	0.000954	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000708	0.000936	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000706	0.000934	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFNB1—peripheral nervous system neoplasm	0.000699	0.000924	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000695	0.00092	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000687	0.000908	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000677	0.000895	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—peripheral nervous system neoplasm	0.000674	0.000891	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HGF—peripheral nervous system neoplasm	0.000666	0.000881	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000659	0.000872	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.000654	0.000865	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—peripheral nervous system neoplasm	0.000644	0.000851	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000642	0.000849	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00064	0.000847	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MET—peripheral nervous system neoplasm	0.000627	0.000829	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000625	0.000827	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000616	0.000815	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000614	0.000812	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000604	0.000798	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.0006	0.000794	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000599	0.000792	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00058	0.000767	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—peripheral nervous system neoplasm	0.000569	0.000752	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000569	0.000752	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000545	0.00072	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HGF—peripheral nervous system neoplasm	0.000539	0.000713	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000535	0.000708	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.00053	0.000701	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000529	0.0007	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000513	0.000679	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000506	0.000669	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000501	0.000663	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000494	0.000653	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000489	0.000646	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000487	0.000644	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTPN11—peripheral nervous system neoplasm	0.000486	0.000642	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000476	0.000629	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000471	0.000623	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000458	0.000606	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000425	0.000562	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000416	0.000551	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—peripheral nervous system neoplasm	0.000413	0.000546	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTPN11—peripheral nervous system neoplasm	0.000394	0.00052	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000387	0.000512	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—peripheral nervous system neoplasm	0.000384	0.000508	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MET—peripheral nervous system neoplasm	0.000384	0.000508	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.00038	0.000503	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000371	0.000491	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000367	0.000485	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000357	0.000473	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000355	0.000469	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000349	0.000462	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000349	0.000461	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000349	0.000461	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000327	0.000432	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000324	0.000428	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000321	0.000425	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000317	0.00042	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—peripheral nervous system neoplasm	0.000311	0.000411	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000302	0.0004	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	0.000301	0.000398	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000295	0.00039	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—peripheral nervous system neoplasm	0.000292	0.000386	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	0.000289	0.000382	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000281	0.000371	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	0.000278	0.000367	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000277	0.000367	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000267	0.000353	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000255	0.000337	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—peripheral nervous system neoplasm	0.000237	0.000313	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	0.000232	0.000307	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000225	0.000298	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	0.000223	0.000294	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	0.000214	0.000283	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—peripheral nervous system neoplasm	0.000214	0.000283	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000213	0.000282	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000193	0.000255	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—peripheral nervous system neoplasm	0.000189	0.000249	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000182	0.000241	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—peripheral nervous system neoplasm	0.000173	0.000229	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000156	0.000207	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000154	0.000204	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—peripheral nervous system neoplasm	0.000153	0.000202	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000152	0.000202	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000147	0.000194	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	0.000145	0.000192	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	0.000141	0.000186	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000138	0.000183	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000138	0.000182	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	0.000119	0.000157	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000118	0.000156	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000116	0.000154	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000116	0.000153	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000113	0.00015	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	0.000112	0.000148	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000108	0.000143	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	9.13e-05	0.000121	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	8.96e-05	0.000118	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.87e-05	0.000117	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.48e-05	0.000112	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.49e-05	9.9e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	3.19e-05	4.22e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.46e-05	3.26e-05	CbGpPWpGaD
